KARLE WATERS: Open Payments
NPI 1669096137 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 42 payments from 17 companies in 2025. Trend: 2023 $805 · 2024 $777 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $241 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| PFIZER INC. | 3 | $58 |
| Novo Nordisk Inc | 3 | $51 |
| ALK-Abello, Inc | 2 | $49 |
| Lilly USA, LLC | 3 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Exact Sciences Corporation | 1 | $26 |
| Lundbeck LLC | 1 | $22 |
Products named: VRAYLAR, Auvelity, UBRELVY, JARDIANCE, PAXLOVID, XIFAXAN, Wegovy, REXULTI.
Industry payments across KY — which companies pay providers there.
